micro-community-banner
Profile Image
  • Add Media
  • Saved

1yr
A Wrap Up of The American College of Cardiology 2024 Scientific Session

This year’s meeting marked the 75th anniversary of ACC and included practice-changing information on the prevention, diagnosis, and treatment of the full spectrum of cardiovascular diseases. Click to access our postconference wrap-up report.

  • Saved

1yr
Cardiovascular Risk Factors and Complications in Patients With Systemic Lupus Erythematosus With and Without Nephritis: a Systematic Review and Meta-Analysis

Cardiovascular Risk Factors and Complications in Patients With Systemic Lupus Erythematosus With and Without Nephritis: a Systematic Review and Meta-Analysis

Source : https://pubmed.ncbi.nlm.nih.gov/38519060/

CRD42022314682.

Patients with systemic lupus erythematosus and lupus nephritis showed significantly higher risk of hypertension, hyperlipidemia, and type 2 diabetes compared with those without lupus nephritis.

Profile Image
  • Saved

1yr
Primary and Secondary Prevention of Stroke and Cardiovascular Events Using Evolocumab and Alirocumab: Meta-Analysis of Randomized Controlled Trials

Primary and Secondary Prevention of Stroke and Cardiovascular Events Using Evolocumab and Alirocumab: Meta-Analysis of Randomized Controlled Trials

Source : https://pubmed.ncbi.nlm.nih.gov/38529927/

Our findings indicate that evolocumab and alirocumab are significantly effective without increasing the risk of hemorrhagic stroke. Based on this, the PCSK9 inhibitors can be highly recommended for cholesterol management.

These findings indicate that evolocumab and alirocumab are significantly effective without increasing the risk of hemorrhagic stroke.

Profile Image
  • Saved

2yr
Updates from The American College of Cardiology Scientific Session

The American College of Cardiology (ACC) 2024 Annual Scientific Session (ACC.24) is taking place April 6 to 8, 2024, in Atlanta. This year’s meeting marks the 75th anniversary of ACC and features seven guideline-specific sessions and 23 late-breaking trials, among other key sessions on the prevention, diagnosis, and treatment of the full spectrum of cardiovascular diseases (CVDs).

  • Saved

2yr
Online Health Information Behaviour and Its Association With Statin Adherence in Patients With High Cardiovascular Risk: a Prospective Cohort Study

Online Health Information Behaviour and Its Association With Statin Adherence in Patients With High Cardiovascular Risk: a Prospective Cohort Study

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10956144/

Statins are effective for preventing cardiovascular disease. However, many patients decide not to take statins because of negative influences, such as online misinformation. Online health information may affect decisions on...

Patients with high CV risk who actively searched for online health information had lower statin adherence, and this relationship was mediated by higher concerns about statins.

Profile Image